Temat: "Vaccines, Synthetic" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: UV-C irradiation as an effective tool for sterilization of porcine chimeric VP1-PCV2bCap recombinant vaccine.
Autorzy:: Vrablikova A; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic. .
Fojtikova M; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Hezova R; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Simeckova P; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Brezani V; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Strakova N; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Fraiberk M; Faculty of Science, Charles University, Albertov 6, 128 00, Prague, Czech Republic.
Kotoucek J; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Masek J; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Psikal I; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19337. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Vaccines, Synthetic*
Viruses*
Mice ; Animals ; Swine ; Sterilization ; Recombinant Proteins/genetics ; Ultraviolet Rays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Autorzy:: Hentzien M; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; University of Reims Champagne-Ardenne, Reims, France.
Bonnet F; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France.
Bernasconi E; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Biver E; Division of Bone Diseases, Geneva University Hospitals, Geneva, Switzerland.
Braun DL; Division Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Munting A; Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudoise (CHUV), Lausanne, Switzerland.
Leuzinger K; Clinical Virology, University Hospital Basel, Basel, Switzerland.
Leleux O; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France.
Musardo S; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Prendki V; Division of Infectious Disease, Geneva University Hospital, Geneva, Switzerland.
Schmid P; Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital, St Gallen, Switzerland.
Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Walti CS; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Wittkop L; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, F-33000, France.; Inria équipe SISTM team, Talence, France.
Appay V; Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, 33000, France.
Didierlaurent AM; Department of Pathology and Immunology, Center of Vaccinology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. .
Calmy A; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 19; Vol. 24 (1), pp. 329. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Herpes Zoster Vaccine*
Neuralgia, Postherpetic*/prevention & control
HIV Infections*/complications
HIV Infections*/drug therapy
Herpes Zoster*/epidemiology
Humans ; Middle Aged ; Aged ; Quality of Life ; Herpesvirus 3, Human ; Vaccines, Synthetic ; Immunity ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
Autorzy:: Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Naicker N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Jani I; Instituto Nacional de Saude, Maputo, Mozambique.
Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Hunidzarira P; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Sebe M; Aurum Institute, Tembisa, Gauteng, South Africa.
Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Polakowski L; DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America.
Ramirez S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Nebergall M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Sikhosana L; Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa.
Heptinstall J; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Diazgranados CA; Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America.
Koutsoukos M; GSK, Wavre, Belgium.
Van Der Meeren O; Previously GSK, Rixensart, Belgium.
Barnett SW; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Kanesa-Thasan N; Formerly GSK, Rockville, Maryland, United States of America.
Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Mngadi K; Aurum Institute, Tembisa, Gauteng, South Africa.
Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Pokaż więcej
Corporate Authors:: HVTN 107 Protocol Team
Źródło:: PLoS medicine [PLoS Med] 2024 Mar 19; Vol. 21 (3), pp. e1004360. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Typ publikacji:: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms:: AIDS Vaccines*/adverse effects
Alum Compounds*
HIV Infections*/prevention & control
HIV-1*
Polysorbates*
Squalene*
Adult ; Humans ; Adjuvants, Immunologic ; HIV Antibodies ; Immunogenicity, Vaccine ; Immunoglobulin A ; Immunoglobulin G ; Vaccines, Combined ; Vaccines, Synthetic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor.
Autorzy:: Kim JY; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.; Department of Biomedical Science, Graduate School, Catholic University of Daegu, Daegu 38430, Republic of Korea.
Park SY; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Lee G; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Park SH; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Jin JS; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Kim D; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Park JH; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Jeong SY; Department of Biomedical Science, Graduate School, Catholic University of Daegu, Daegu 38430, Republic of Korea.
Ko YJ; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 16; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Foot-and-Mouth Disease*
Foot-and-Mouth Disease Virus*
Viral Vaccines*
Animals ; Swine ; Virus Inactivation ; Capsid Proteins ; Vaccines, Synthetic ; Bioreactors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Novel Universal Recombinant Rotavirus A Vaccine Candidate: Evaluation of Immunological Properties.
Autorzy:: Granovskiy DL; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Khudainazarova NS; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Evtushenko EA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Ryabchevskaya EM; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Kondakova OA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Arkhipenko MV; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Kovrizhko MV; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Kolpakova EP; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Tverdokhlebova TI; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Nikitin NA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Karpova OV; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 12; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Rotavirus*/genetics
Rotavirus Infections*
Gastroenteritis*/prevention & control
Rotavirus Vaccines*/genetics
Animals ; Mice ; Child ; Humans ; Child, Preschool ; Prospective Studies ; Antibodies, Viral ; Vaccines, Synthetic/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Recombinant production of SAG1 fused with xylanase in Pichia pastoris induced higher protective immunity against Eimeria tenella infection in chicken.
Autorzy:: Liu C; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Wei H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Liang R; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Wang Y; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Su X; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Tu T; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Luo H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Yao B; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Ding J; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Tang X; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Huang H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Zhang H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.; Pokaż więcej
Źródło:: Microbial biotechnology [Microb Biotechnol] 2024 Mar; Vol. 17 (3), pp. e14447.
Typ publikacji:: Journal Article
MeSH Terms:: Eimeria tenella*/genetics
Coccidiosis*/prevention & control
Coccidiosis*/veterinary
Saccharomycetales*
Animals ; Chickens ; Antigens, Surface ; Antigens, Protozoan/genetics ; Recombinant Proteins/genetics ; Vaccines, Synthetic/genetics
SCR Organism:: Komagataella pastoris

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals.
Autorzy:: Borca MV; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Ramirez-Medina E; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Espinoza N; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Rai A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Spinard E; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Velazquez-Salinas L; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Valladares A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Silva E; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Burton L; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Meyers A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Clark J; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Wu P; Plum Island Animal Disease Center, U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Orient, NY 11957, USA.
Gay CG; Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA.
Gladue DP; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: African Swine Fever Virus*
African Swine Fever*
Viral Vaccines*/genetics
Swine ; Animals ; Sus scrofa ; Virulence ; Vaccines, Synthetic/genetics ; Vaccines, Attenuated/genetics ; Recombinant Proteins/genetics ; Gene Deletion

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection.
Autorzy:: Zhang F; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Ni L; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Zhang Z; Department of Geriatrics and Special Needs Medicine, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.
Luo X; Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Wang X; Key Laboratory of Radiation Oncology of Taizhou, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, 317000, China.
Zhou W; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Chen J; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Liu J; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Qu Y; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .
Liu K; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .
Guo L; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China. .; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, 750004, China. .; Pokaż więcej
Źródło:: Microbial cell factories [Microb Cell Fact] 2024 Feb 24; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Journal Article
MeSH Terms:: Helicobacter pylori*
Animals ; Mice ; Immunity, Mucosal ; Virulence Factors ; Bacterial Vaccines ; Urease ; Vaccines, Synthetic ; Mice, Inbred BALB C ; Administration, Oral

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children.
Autorzy:: Karron RA; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Herbert K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Wanionek K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Schmidt AC; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.; Present Affiliation: Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Schaap-Nutt A; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.; Pokaż więcej
Źródło:: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 173-176.
Typ publikacji:: Clinical Trial, Phase I; Journal Article
MeSH Terms:: Parainfluenza Virus 2, Human*
Vaccines, Synthetic*
Adult ; Child ; Humans ; Antibodies, Viral ; Parainfluenza Virus 1, Human ; Parainfluenza Virus 3, Human ; Vaccines, Attenuated

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Autorzy:: Arevalo CP; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bolton MJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Le Sage V; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ye N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Furey C; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Alameh MG; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Drapeau EM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Parkhouse K; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Garretson T; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morris JS; Department of Biostatistics Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Moncla LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Tam YK; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
Fan SHY; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
Lakdawala SS; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Weissman D; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hensley SE; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 899-904. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Orthomyxoviridae Infections*/prevention & control
Vaccines, Combined*/genetics
Vaccines, Combined*/immunology
mRNA Vaccines*/genetics
mRNA Vaccines*/immunology
Vaccines, Synthetic*/genetics
Vaccines, Synthetic*/immunology
Influenza A virus*/immunology
Influenza B virus*/immunology
Animals ; Mice ; Ferrets ; Nucleosides/chemistry ; Nucleosides/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Cross Reactions

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: The influenza universe in an mRNA vaccine.
Autorzy:: Kelvin AA; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Falzarano D; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 827-828. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:: Journal Article; Comment
MeSH Terms:: Influenza B virus*/immunology
Influenza Vaccines*/genetics
Influenza Vaccines*/immunology
Influenza, Human*/prevention & control
mRNA Vaccines*/genetics
mRNA Vaccines*/immunology
Vaccines, Synthetic*/genetics
Vaccines, Synthetic*/immunology
Alphainfluenzavirus*/immunology
Animals ; Mice ; Ferrets

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
Autorzy:: Kapczynski DR; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Chrzastek K; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Shanmugasundaram R; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Zsak A; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Segovia K; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Sellers H; Department of Population Health, College of Veterinary Medicine, The University of Georgia, 956 College Station Road, 30602, Athens, Athens, GA, U.S.
Suarez DL; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.. .; Pokaż więcej
Źródło:: Virology journal [Virol J] 2023 Dec 15; Vol. 20 (1), pp. 298. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines*
Influenza A Virus, H5N2 Subtype*/genetics
Influenza in Birds*
Influenza A virus*
Animals ; Chickens ; Vaccines, Synthetic ; Hemagglutinin Glycoproteins, Influenza Virus/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
Autorzy:: Watanabe S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Yoshikawa T; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Kaku Y; Division of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Kurosu T; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Fukushi S; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Sugimoto S; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Nishisaka Y; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Fuji H; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Marsh G; Australian Centre for Disease Preparedness, CSIRO, Geelong, VIC, Australia.
Maeda K; Division of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Ebihara H; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Morikawa S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Shimojima M; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Saijo M; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.; Public Health Office, Health and Welfare Bureau, Sapporo Municipal Government, Sapporo, Hokkaido, Japan.; Pokaż więcej
Źródło:: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Dec 15; Vol. 17 (12), pp. e0011851. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Nipah Virus*/genetics
Viral Vaccines*/genetics
Henipavirus Infections*/prevention & control
Animals ; Cricetinae ; Humans ; Vaccinia virus/genetics ; Glycoproteins/genetics ; Glycoproteins/metabolism ; Vaccines, Synthetic/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
Autorzy:: Pourhashem Z; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Nourani L; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sani JJ; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Yousefi H; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Pirahmadi S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sabouri M; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Raz A; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Djadid ND; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Zakeri S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .
Mehrizi AA; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2023 Dec 09; Vol. 22 (1), pp. 374. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria Vaccines*
Malaria, Falciparum*
Animals ; Mice ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; Antibodies, Protozoan ; Antigens, CD ; Antigens, Protozoan ; Immunoglobulin G ; Iran ; Oocysts ; Plasmodium falciparum ; Protozoan Proteins/metabolism ; Vaccines, Synthetic ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Oral Immunization with Attenuated Salmonella Choleraesuis Expressing the FedF Antigens Protects Mice against the Shiga-Toxin-Producing Escherichia coli Challenge.
Autorzy:: Zhang G; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Fu Y; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Li Y; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Li Q; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Wang S; Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611-0880, USA.
Shi H; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University (JIRLAAPS), Yangzhou 225009, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 Nov 30; Vol. 13 (12). Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Shiga-Toxigenic Escherichia coli*/genetics
Salmonella enterica*
Escherichia coli Infections*
Salmonella Vaccines*
Animals ; Mice ; Swine ; Salmonella ; Vaccines, Synthetic/genetics ; Immunization
SCR Organism:: Salmonella enterica subsp. enterica

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Plant-based production of a protective vaccine antigen against the bovine parasitic nematode Ostertagia ostertagi.
Autorzy:: Zwanenburg L; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Borloo J; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Decorte B; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Bunte MJM; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Mokhtari S; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Serna S; Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramon 194, 20014, Donostia San Sebastián, Spain.; CIBER-BBN, Paseo Miramón 194, 20014, San Sebastian, Spain.
Reichardt NC; Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramon 194, 20014, Donostia San Sebastián, Spain.; CIBER-BBN, Paseo Miramón 194, 20014, San Sebastian, Spain.
Seys LJM; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
van Diepen A; Department of Parasitology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Schots A; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Wilbers RHP; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Hokke CH; Department of Parasitology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Claerebout E; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Geldhof P; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20488. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Ostertagiasis*/prevention & control
Ostertagiasis*/veterinary
Cattle Diseases*
Cattle ; Animals ; Ostertagia/genetics ; Vaccination/veterinary ; Vaccines, Synthetic/genetics ; Recombinant Proteins/genetics ; Parasite Egg Count

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
Autorzy:: Le T; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Sun C; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Chang J; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Zhang G; Departments of Animal Science, School of Agriculture, Ningxia University, Yinchuan 750021, China.
Yin X; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.; Pokaż więcej
Źródło:: Viruses [Viruses] 2022 Feb 15; Vol. 14 (2). Date of Electronic Publication: 2022 Feb 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Communicable Disease Control*
Communicable Diseases/*virology
Communicable Diseases, Emerging/*prevention & control
Vaccines, Synthetic/*genetics
Vaccines, Synthetic/*immunology
Zoonoses/*prevention & control
mRNA Vaccines/*genetics
mRNA Vaccines/*immunology
Animals ; Communicable Diseases/classification ; Communicable Diseases, Emerging/immunology ; Humans ; Vaccines, Synthetic/analysis ; Vaccines, Synthetic/classification ; Zoonoses/immunology ; Zoonoses/transmission ; mRNA Vaccines/analysis ; mRNA Vaccines/classification

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits.
Autorzy:: Awasthi M; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Macaluso A; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Goebel SJ; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Luea E; Southern Research, Birmingham, AL 35205, USA.
Noyce RS; Department of Medical Microbiology & Immunology, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Nasar F; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Daugherty B; Tonix Pharmaceuticals, Chatham, NJ 07928, USA.
Bavari S; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Lederman S; Tonix Pharmaceuticals, Dartmouth, MA 02745, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Oct 21; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*
Poxviridae*
Cricetinae ; Rabbits ; Animals ; Mesocricetus ; SARS-CoV-2/genetics ; Vaccines, Attenuated/adverse effects ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/genetics ; Antibodies, Viral ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus/genetics ; Antibodies, Neutralizing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Protective efficacy of six recombinant proteins as vaccine candidates against Echinococcus granulosus in dogs.
Autorzy:: Shao G; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Hua R; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Song H; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Chen Y; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Zhu X; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Hou W; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Li S; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Yang A; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Yang G; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.; Pokaż więcej
Źródło:: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Oct 23; Vol. 17 (10), pp. e0011709. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Echinococcus granulosus*/genetics
Echinococcosis*/prevention & control
Echinococcosis*/veterinary
Dog Diseases*/prevention & control
Dog Diseases*/parasitology
Dogs ; Animals ; Vaccines, Synthetic/genetics ; Recombinant Proteins/genetics ; Immunoglobulin G

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools.
Autorzy:: da Silva MK; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Campos DMO; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Akash S; Department of Pharmacy, Daffodil International University, Sukrabad, Dhaka 1207, Bangladesh.
Akter S; Bangladesh Council of Scientific & Industrial Research (BCSIR), Dhaka 1205, Bangladesh.
Yee LC; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Kota Bharu 11800, Kelantan, Malaysia.
Fulco UL; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Oliveira JIN; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Oct 21; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/prevention & control
Humans ; COVID-19 Vaccines ; Vaccinology/methods ; Proteomics ; mRNA Vaccines ; Vaccines, Synthetic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Vaccines, Synthetic"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język